1. Academic Validation
  2. Inhibitory interaction of flavonoids with organic cation transporter 2 and their structure-activity relationships for predicting nephroprotective effects

Inhibitory interaction of flavonoids with organic cation transporter 2 and their structure-activity relationships for predicting nephroprotective effects

  • J Appl Toxicol. 2023 Apr 14. doi: 10.1002/jat.4474.
Huixin Tan 1 Fenghe Wang 1 Jiahuan Hu 1 Xiaoyan Duan 1 Wanting Bai 1 Xinbo Wang 1 Baolian Wang 1 Yan Su 2 Jinping Hu 1 3
Affiliations

Affiliations

  • 1 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Department of Drug Metabolism, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
  • 2 Department of Health Management and Service, Cangzhou Medical College, Hebei, 061001, China.
  • 3 No. 37 Yong Wang Road, Daxing District, Beijing.
Abstract

Organic cation transporter 2 (OCT2) is mainly responsible for the renal secretion of various cationic drugs, closely associated with drug-induced acute kidney injury (AKI). Screening and identifying potent OCT2 inhibitors with little toxicity in Natural Products in reducing OCT2-mediated AKI is of great value. Flavonoids are enriched in various vegetables, fruits, and herbal products, and some were reported to produce transporter-mediated DDIs. This study aimed to screen potential inhibitors of OCT2 from 96 Flavonoids, assess the nephroprotective effects on cisplatin-induced kidney injury, and clarify the structure-activity relationships of Flavonoids with OCT2. Ten Flavonoids exhibited significant inhibition (>50 %) on OCT2 in OCT2-HEK293 cells. Among them, the six most potent flavonoid inhibitors, including pectolinarigenin, biochanin A, luteolin, chrysin, 6-hydroxyflavone, and 6-methylflavone markedly decreased cisplatin-induced cytotoxicity. Moreover, in cisplatin-induced renal injury models, they also reduced serum blood urea nitrogen (BUN) and creatinine levels to different degrees, the best of which was 6-methylflavone. The pharmacophore model clarified that the aromatic ring, hydrogen bond acceptors, and hydrogen bond donors might play a vital role in the inhibitory effect of Flavonoids on OCT2. Thus, our findings would pave the way to predicting the potential risks of flavonoid-containing food/herb-drug interactions in humans and optimising flavonoid structure to alleviate OCT2-related AKI.

Keywords

Cisplatin; Drug-drug interactions; Flavonoids; Inhibition; Organic cation transporter 2; Structure-activity relationship.

Figures
Products